NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Estimated value
£608.0m
Awarded value
£608.0m
Awarded 11 Mar 2024
Suppliers
1
Lots
1
1 awarded
Published
03 Apr 2024
Deadline 01 Dec 2023
Description
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).
Scope
- Reference
- CF-2269700D0O000000rwimUAA
- Total value
- £608,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2024 to 30 Mar 2028
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 01 Dec 2023, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£608.0m
Award date
11 Mar 2024
Contract start
31 Mar 2024
Contract end
30 Mar 2028